EUVIMEDEUVIMED entdecken
Crossref

A Quality by Design (QbD) Approach for the Development and Validation of an RP-HPLC Method for Azelnidipine Quantification

Kirankumar Jalindar Gavali, Meenaxi Maruti Maste, Nikhil S. Gawas, Shailendra Suryawanshi, Priya P Shetti

Advances in Pharmacology and Pharmacy · 2026-10 · 14 (4) · 460-479

DOI: 10.13189/app.2026.140404 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Pharmacology and Pharmacy, 2026-10. Verfasst von Kirankumar Jalindar Gavali und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gavali, K. J., Maste, M. M., Gawas, N. S., Suryawanshi, S., & Shetti, P. P. (2026). A Quality by Design (QbD) Approach for the Development and Validation of an RP-HPLC Method for Azelnidipine Quantification. Advances in Pharmacology and Pharmacy, 14(4), 460-479. https://doi.org/10.13189/app.2026.140404

Vancouver

Gavali KJ, Maste MM, Gawas NS, Suryawanshi S, Shetti PP. A Quality by Design (QbD) Approach for the Development and Validation of an RP-HPLC Method for Azelnidipine Quantification. Advances in Pharmacology and Pharmacy. 2026;14(4):460-479. doi:10.13189/app.2026.140404

BibTeX
@article{Gavali2026,
  author = {Gavali, Kirankumar Jalindar and Maste, Meenaxi Maruti and Gawas, Nikhil S. and Suryawanshi, Shailendra and Shetti, Priya P},
  title = {A Quality by Design (QbD) Approach for the Development and Validation of an RP-HPLC Method for Azelnidipine Quantification},
  journal = {Advances in Pharmacology and Pharmacy},
  year = {2026},
  volume = {14},
  number = {4},
  pages = {460--479},
  doi = {10.13189/app.2026.140404}
}
Kostenlos starten →